FindTrial
Sign In

Study on the the Assessment of Molecularly Targeted Drugs Efficacy for GIST Using Multimodality Ultrasound Image

Study on the the Assessment of Molecularly Targeted Drugs Efficacy for GIST Using Multimodality Ultrasound Image

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2500106111
Enrollment
Unknown
Registered
2025-07-17
Start date
2025-08-01
Completion date
Unknown
Last updated
2025-07-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Gastrointestinal stromal tumors

Interventions

The group with drug therapy:None

Sponsors

The First Affiliated Hospital of Chongqing Medical University
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. Patients with pathologically confirmed gastrointestinal stromal tumor (GIST) receiving targeted drug therapy, including those with unresectable tumors or postoperative recurrence. 2. Patients who voluntarily accepted the treatment regimen. 3. Patients able to adhere to strict follow-up schedules. 4. Patients who understood and were willing to sign the informed consent form.

Exclusion criteria

Exclusion criteria: 1. Patients with severe hepatic or renal impairment. 2. Patients with severe psychiatric disorders impairing normal communication. 3. Patients undergoing radiotherapy.

Design outcomes

Primary

MeasureTime frame
Tumor size;Blood Flow Semi-Quantitative Grading;Elastic Young's Modulus;—

Countries

China

Contacts

Public ContactHe Xuemei

The First Affiliated Hospital of Chongqing Medical University

406900598@qq.com+86 136 1823 5936

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026